GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Total Debt per Share

Cyfuse Biomedical KK (TSE:4892) Total Debt per Share : 円98.88 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Total Debt per Share?

円98.88 (As of Jun. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Cyfuse Biomedical KK's Total Debt Per Share for the quarter that ended in Jun. 2024 was 円98.88.

Cyfuse Biomedical KK Total Debt per Share Historical Data

The historical data trend for Cyfuse Biomedical KK's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Total Debt per Share Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Debt per Share
74.11 1,135.85 116.83 115.65

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 109.30 104.86 115.65 102.14 98.88

Cyfuse Biomedical KK Total Debt per Share Calculation

Cyfuse Biomedical KK's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(345.00+568.00)/7.89
=115.65

Cyfuse Biomedical KK's Total Debt Per Share for the quarter that ended in Jun. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(336.00+468.00)/8.13
=98.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Total Debt per Share
Comparable Companies
TSE:4586 TSE:4539 TSE:4597 TSE:4512 TSE:4883 TSE:4524 TSE:4582 TSE:4574 TSE:4538 TSE:4595 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Website
https://www.cyfusebio.com
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK Headlines

No Headlines